Hyper Insight™ – Infarct | Acute Infarct Detection on NCCT

Hyper Insight AI Detection Solutions

Comprehensive Stroke AI Platform

Hyper Insight™ – Infarct

FDA in Progress

Acute Cerebral Infarction Detection · NCCT

AI software that rapidly detects and localizes suspicious acute cerebral infarction on non-contrast brain CT. It highlights abnormal regions, provides probability scores, and offers ROI visualization with ASPECTS scoring.

AI AIS Detection
(LVO, MeVO, SVO)

ROI Visualization

Probability Scores

ASPECTS Score

Automatic Report

Medical Insight+™ Brain Infarct

RUOKFDA

AI AIS Detection
(LVO, MeVO, SVO)

ROI Visualization

Probability Scores

ASPECTS Score

Automatic Report

Not cleared or approved by the US Food and Drug Administration (FDA). This software is not for clinical use in the United States and is provided for research, evaluation, and educational purposes only.

Hyper Insight™ – Infarct Performance

Standalone AI performance for acute cerebral infarction detection on NCCT.

Sensitivity88.9%

Specificity91.4%

Source: Clinical Study Report, Protocol No. SKAICI-01, Ver. 3.1, September 22, 2023, Seoul National University Hospital & Ajou University Hospital, Korea.

Performance metrics reflect the latest metrics of internal validation.

Top 15 Industry Features Avail.

Worklist prioritization / triagePACS integration / automated DICOM routingCloud or hybrid deploymentSecure team communication / collaboration

Industry-standard integration capabilities available with PurpleAI deployments.